Orders | Qty | Bid |
---|---|---|
4 | 34 | 1173.4 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
Ask | Qty | Orders |
---|---|---|
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
0 | 0 | 0 |
Max Healthcare Institute Limited is one of India’s leading private hospital networks with a 25-year history of delivering tertiary and quaternary care. As on March 31, 2025, the network comprised 22 healthcare facilities with a capacity of over 5,100 beds, supported by advanced technologies and multidisciplinary clinical teams. Beyond hospitals, the Company’s ecosystem includes Max@Home (home healthcare) across 15+ cities and Max Lab (diagnostics) in 50+ cities, expanding access to care beyond traditional settings. Its clinical strengths span oncology, cardiac sciences, neurosciences, orthopaedics, renal sciences, transplants and more, with robotic surgery and modern imaging platforms deployed across the network.
Geographically, Max Healthcare serves patients across Delhi NCR (including Saket, Rajendra Place, Patparganj, Shalimar Bagh, Dwarka, Vaishali, Gurugram, Panchsheel Park, Noida and Lajpat Nagar) as well as Mumbai, Mohali, Bathinda, Dehradun, Lucknow and Nagpur. The Group had 10 subsidiaries as on March 31, 2025, including one step-down subsidiary.
External rating: CARE Ratings reaffirmed the Company’s long-term rating at CARE AA+ and short-term rating at CARE A1+.
Max Healthcare provides tertiary and quaternary healthcare services across specialities, supported by diagnostics, ambulatory care and home-based services through Max Lab and Max@Home.
As of March 31, 2025, the network comprised 22 healthcare facilities and over 5,100 beds across 11 Indian cities, with home healthcare in 15+ cities and diagnostics in 50+ cities.
The Company had 10 subsidiaries, including one step-down subsidiary, as on March 31, 2025.